Acurx Pharmaceuticals, Inc. ACXP 深 沪
等待开盘 03-26 09:30:00 美东时间
4.27
-0.010
-0.23%
华盛通- 最 高4.58
- 今 开4.47
- 成交量 25.84万股
- 最 低 4.21
- 昨 收 4.28
- 总市值 1087.45万
- 52周最高 21.00
- 市盈率 静 --
- 换手率 10.15%
- 52周最低 1.3259
- 委 比 -99.92%
- 总股本 254.67万
- 历史最高 176.40
- 量 比 0.11
- 振 幅 8.64%
- 历史最低 1.3259
- 每 手 1
- 风险率 2.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股夜盘 | Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨81.10%，网络齿轮通信涨16.41%
Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨81.10%；网络齿轮通信涨16.41%；BioCryst制药涨14.18%
03-24 15:02
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Serina Therapeutics (AMEX:SER) shares moved upwards by 94.5% to $2.49 d...
03-20 01:05
Earnings Scheduled For March 13, 2026
Companies Reporting Before The Bell • Douglas Elliman (NYSE:DOUG) is likely to ...
03-13 19:11
Acurx Pharmaceuticals Q4 EPS $(0.73) Beats $(1.65) Estimate
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(1.65) by 55.62 percent. This is a 78.53 percent increase over losses of $(3.40) per share
03-13 19:01
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today?
Acurx Pharmaceuticals Inc shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news during the session.
03-12 02:45
Acurx Pharma To Conduct New Clinical Trial In Patients With rCDI While Its Program In Broader CDI Patient Population Is Ready To Advance To Phase 3 International Clinical Trials
Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 International Clinical TrialsAcurx is launching a ground-breaking clinical trial with ibezapolstat in patients with multiply-recurrent
03-09 20:13
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
STATEN ISLAND, N.Y., Feb. 2, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of smal...
02-02 21:00
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
The show airs as sponsored programming with TV commercials by Synergy CHC, Sust...
2025-11-23 00:20
Acurx Pharmaceuticals Q3 EPS $(1.23) Beats $(1.31) Estimate
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.31) by 6.11 percent. This is a 64.35 percent increase over losses of $(3.45) per share
2025-11-12 20:02
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
